Susquehanna International Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.57M | Buy |
17,900
+5,600
| +46% | +$1.11M | ﹤0.01% | 4893 |
|
|
2025
Q4 | $2.33M | Buy |
12,300
+3,300
| +37% | +$634K | ﹤0.01% | 5328 |
|
|
2025
Q3 | $1.59M | Buy |
9,000
+3,500
| +64% | +$520K | ﹤0.01% | 6269 |
|
|
2025
Q2 | $625K | Sell |
5,500
-1,300
| -19% | -$139K | ﹤0.01% | 8651 |
|
|
2025
Q1 | $715K | Sell |
6,800
-5,500
| -45% | -$622K | ﹤0.01% | 8094 |
|
|
2024
Q4 | $1.32M | Sell |
12,300
-1,200
| -9% | -$136K | ﹤0.01% | 6282 |
|
|
2024
Q3 | $1.35M | Sell |
13,500
-21,400
| -61% | -$2.15M | ﹤0.01% | 6150 |
|
|
2024
Q2 | $2.94M | Sell |
34,900
-14,600
| -29% | -$1.16M | ﹤0.01% | 4351 |
|
|
2024
Q1 | $3.62M | Buy |
49,500
+28,400
| +135% | +$2.09M | ﹤0.01% | 4169 |
|
|
2023
Q4 | $1.51M | Sell |
21,100
-9,500
| -31% | -$561K | ﹤0.01% | 6001 |
|
|
2023
Q3 | $1.83M | Sell |
30,600
-2,600
| -8% | -$171K | ﹤0.01% | 5300 |
|
|
2023
Q2 | $2.39M | Sell |
33,200
-7,400
| -18% | -$555K | ﹤0.01% | 4783 |
|
|
2023
Q1 | $2.99M | Buy |
40,600
+31,500
| +346% | +$2.24M | ﹤0.01% | 4337 |
|
|
2022
Q4 | $608K | Sell |
9,100
-83,553
| -90% | -$5.43M | ﹤0.01% | 7356 |
|
|
2022
Q3 | $4.98M | Buy |
92,653
+47,769
| +106% | +$2.81M | ﹤0.01% | 3155 |
|
|
2022
Q2 | $2.5M | Sell |
44,884
-10,900
| -20% | -$619K | ﹤0.01% | 4436 |
|
|
2022
Q1 | $3.92M | Sell |
55,784
-78,067
| -58% | -$5.66M | ﹤0.01% | 4105 |
|
|
2021
Q4 | $12.9M | Buy |
133,851
+13,305
| +11% | +$1.23M | ﹤0.01% | 2370 |
|
|
2021
Q3 | $10.5M | Sell |
120,546
-83,837
| -41% | -$6.48M | ﹤0.01% | 2798 |
|
|
2021
Q2 | $16.7M | Buy |
204,383
+1,764
| +0.9% | +$147K | ﹤0.01% | 2262 |
|
|
2021
Q1 | $19.3M | Buy |
202,619
+35,907
| +22% | +$3.39M | ﹤0.01% | 1923 |
|
|
2020
Q4 | $10.3M | Buy |
166,712
+118,943
| +249% | +$6.78M | ﹤0.01% | 2449 |
|
|
2020
Q3 | $2.84M | Sell |
47,769
-33,343
| -41% | -$2.28M | ﹤0.01% | 3965 |
|
|
2020
Q2 | $5.66M | Sell |
81,112
-110,447
| -58% | -$7M | ﹤0.01% | 2835 |
|
|
2020
Q1 | $8.69M | Sell |
191,559
-114,293
| -37% | -$6.48M | ﹤0.01% | 1897 |
|
|
2019
Q4 | $19.9M | Buy |
305,852
+100,187
| +49% | +$6.7M | 0.01% | 1423 |
|
|
2019
Q3 | $12.8M | Sell |
205,665
-195,726
| -49% | -$12.3M | ﹤0.01% | 1728 |
|
|
2019
Q2 | $28.6M | Sell |
401,391
-100,669
| -20% | -$7.41M | 0.01% | 1039 |
|
|
2019
Q1 | $39.4M | Buy |
502,060
+49,373
| +11% | +$3.74M | 0.02% | 756 |
|
|
2018
Q4 | $38.3M | Buy |
452,687
+274,113
| +154% | +$29.2M | 0.02% | 704 |
|
|
2018
Q3 | $30.6M | Buy |
178,574
+150,842
| +544% | +$22.7M | 0.01% | 1007 |
|
|
2018
Q2 | $3.58M | Buy |
27,732
+17,152
| +162% | +$1.91M | ﹤0.01% | 3145 |
|
|
2018
Q1 | $1.09M | Buy |
10,580
+3,206
| +43% | +$317K | ﹤0.01% | 5055 |
|
|
2017
Q4 | $630K | Sell |
7,374
-9,137
| -55% | -$792K | ﹤0.01% | 6174 |
|
|
2017
Q3 | $1.4M | Sell |
16,511
-152,926
| -90% | -$12.1M | ﹤0.01% | 4601 |
|
|
2017
Q2 | $12.8M | Buy |
169,437
+123,912
| +272% | +$8.67M | 0.01% | 1500 |
|
|
2017
Q1 | $3.01M | Sell |
45,525
-216,245
| -83% | -$14.2M | ﹤0.01% | 3021 |
|
|
2016
Q4 | $16.6M | Buy |
261,770
+219,611
| +521% | +$13.9M | 0.01% | 1184 |
|
|
2016
Q3 | $2.68M | Buy |
42,159
+26,930
| +177% | +$1.98M | ﹤0.01% | 3075 |
|
|
2016
Q2 | $1.13M | Sell |
15,229
-24,205
| -61% | -$1.8M | ﹤0.01% | 4621 |
|
|
2016
Q1 | $2.63M | Buy |
39,434
+6,092
| +18% | +$370K | ﹤0.01% | 3255 |
|
|
2015
Q4 | $2.25M | Sell |
33,342
-57,067
| -63% | -$3.52M | ﹤0.01% | 3799 |
|
|
2015
Q3 | $4.83M | Buy |
90,409
+7,053
| +8% | +$428K | ﹤0.01% | 2715 |
|
|
2015
Q2 | $5.25M | Buy |
83,356
+44,403
| +114% | +$2.42M | ﹤0.01% | 2846 |
|
|
2015
Q1 | $1.87M | Buy |
38,953
+9,778
| +34% | +$375K | ﹤0.01% | 4436 |
|
|
2014
Q4 | $968K | Sell |
29,175
-82,073
| -74% | -$2.67M | ﹤0.01% | 5946 |
|
|
2014
Q3 | $3.26M | Buy |
111,248
+14,106
| +15% | +$468K | ﹤0.01% | 3750 |
|
|
2014
Q2 | $3.77M | Buy |
97,142
+36,549
| +60% | +$1.48M | ﹤0.01% | 3533 |
|
|
2014
Q1 | $2.54M | Sell |
60,593
-121,668
| -67% | -$5.07M | ﹤0.01% | 3922 |
|
|
2013
Q4 | $5.98M | Buy |
182,261
+162,063
| +802% | +$5.28M | ﹤0.01% | 2688 |
|
|
2013
Q3 | $545K | Buy |
+20,198
| New | +$568K | ﹤0.01% | 6293 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Susquehanna International Group's LGND Position: Q1 2026 in Review
Susquehanna International Group increased its Ligand Pharmaceuticals (LGND) stake by 24% in Q1 2026, buying an estimated $256K and bringing the position to 6,703 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #7170.
Susquehanna International Group first reported a position in LGND in Q2 2013 and has held it in 42 quarters since. The position peaked at $13.5M in Q2 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Susquehanna International Group held 6,703 shares of Ligand Pharmaceuticals worth $1.34M as of Q1 2026.
- Susquehanna International Group bought 1,294 Ligand Pharmaceuticals shares in Q1 2026, an estimated $256K.
- Ligand Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7170 holding.
- Susquehanna International Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
- Susquehanna International Group's Ligand Pharmaceuticals position peaked at $13.5M in Q2 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.